-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EHdV7Ul3AR5qfICHdrJCnjAWDSdxZy8Uhsv1ly3PGpsecd7fuijOPpX8vC/vxpjm GWD2E4GTPXuXUsDnat44QQ== 0000890163-08-000685.txt : 20081113 0000890163-08-000685.hdr.sgml : 20081113 20081113113850 ACCESSION NUMBER: 0000890163-08-000685 CONFORMED SUBMISSION TYPE: AW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20081113 DATE AS OF CHANGE: 20081113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADEONA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000894158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133808303 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: AW SEC ACT: SEC FILE NUMBER: 333-139354 FILM NUMBER: 081183470 BUSINESS ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: 734-332-7800 MAIL ADDRESS: STREET 1: 3985 RESEARCH PARK DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20061214 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970730 FORMER COMPANY: FORMER CONFORMED NAME: SHEFFIELD MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19940606 AW 1 s11-8884_aw.htm FORM AW

 

ADEONA PHARMACEUTICALS, INC.

3930 Varsity Drive

Ann Arbor, MI 48108

 

 

November 13, 2008

 

 

FILED VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

 

RE: Adeona Pharmaceuticals, Inc.

Request to Withdraw Post-Effective Amendment No. 1 to

Registration Statement on Form SB-2 File No. 333-139354

 

Ladies and Gentlemen:

 

Pursuant to Rule 477(a) of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Adeona Pharmaceuticals, Inc. (formerly Pipex Pharmaceuticals, Inc.) (the “Registrant”) hereby requests withdrawal of its Post-Effective Amendment No. 1 filed on January 18, 2008 to its Registration Statement on

Form SB-2 (File No. 333-139354) which was filed with the Securities and Exchange Commission on December 14, 2006.

 

The Registrant wishes to withdraw its Post-Effective Amendment No. 1, which has not gone effective, since all the securities listed on the Post-Effective Amendment No. 1 have either already been sold under the prior registration statement or are Rule 144 eligible. No securities were sold in connection with the Post-Effective Amendment No. 1.

 

If you have any questions regarding this application for withdrawal, please contact the Registrant’s counsel, Hank Gracin at (561)237-0804.

 

 

Sincerely,

 

/s/ Nicholas Stergis

 

Nicholas Stergis

 

Chief Executive Officer

 

 

 

 

-----END PRIVACY-ENHANCED MESSAGE-----